Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

59.20 -3.56 (-5.68%)
Streaming Delayed Price Updated: 12:57 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
45 46 Next >
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
Via The Motley Fool
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout first-quarter earnings report released late Monday. 
Via Benzinga
Why Novo Nordisk Stock Popped After Earnings
Buying Novo Nordisk stock looks like the cheapest way to invest in GLP-1 drugs. 
Via The Motley Fool
Why Is Hims & Hers Stock Skyrocketing?
Via The Motley Fool
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
Hims & Hers is on fire right now. 
Via The Motley Fool
Earnings Scheduled For May 5, 2025
 
Via Benzinga
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves. 
Via Chartmill
2 Volatile Stocks Worth Your Attention and 1 to Steer Clear Of
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 20.2% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts'... 
Via StockStory
Topics Artificial Intelligence
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
Good news for Hims & Hers stock spooks Lilly and Novo investors. 
Via The Motley Fool
Topics Earnings
Which stocks are most active on Tuesday?
These stocks are making the most noise in today's session. Stay tuned for the latest updates! 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q1 CY2025, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded... 
Via StockStory
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as the latest quarterly earnings show momentum. 
Via MarketBeat
What's Going On With Hims & Hers Stock Tuesday?
Hims & Hers stock was trading lower but has since reversed and began trading higher after the company reported first-quarter earnings on Monday after the market closed. 
Via Benzinga
Looking At Hims & Hers Health's Recent Unusual Options Activity
 
Via Benzinga
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook
The company recently inked a deal with Novo Nordisk. But will that bolster current-quarter sales? 
Via Investor's Business Daily
Hims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It Off
Its second-quarter revenue guidance of $530 million-$550 million fell short of the $564.57 million consensus estimate. 
Via Stocktwits
Topics Earnings
Hims & Hers Health’s (NYSE:HIMS) Q1: Beats On Revenue, Full-Year Outlook Slightly Exceeds Expectations
Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 111% year on year to $586 million. Revenue guidance for the full... 
Via StockStory
Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide
Hims & Hers Health reports first-quarter revenue of $586.01 million, beating estimates of $538.2 million, according to Benzinga. 
Via Benzinga
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
ETFs Last Week: Tech-Fueled Rally Powers Gains During Trade Optimism
Wall Street rebounds from tariff losses, with S&P 500 recording second consecutive weekly gain. Top performers were tech giants and leveraged ETFs. 
Via Benzinga
Topics ETFs Stocks World Trade
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hims & Hers Names New COO. Stock Rallies.
Hims stock rose Monday after the telehealth program named technology industry veteran Nader Kabbani as its new chief operating officer. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Hims & Hers Appoints Ex-Amazon Exec Ahead Of Q1 Results
Hims & Hers Health shares are trading marginally lower Monday morning. The company earlier appointed Nader Kabbani as its new Chief Operations Officer, ahead of Q1 results. 
Via Benzinga
Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery
Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to expand into other healthcare areas. 
Via Benzinga
Hims & Hers Appoints Amazon Veteran Nader Kabbani COO To Support Expansion
A nearly 20-year Amazon veteran, Nader Kabbani said he was drawn to Hims & Hers by its potential to expand access to fast, reliable, and high-quality care. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
From Hims & Hers
Via Business Wire
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them? 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.